Price $2.67 |
Market Cap
13.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.36
|
P/S
8.37
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-12.1K
|
FCF
-
|
|
Op. Margin
-952.20%
|
Net Margin
-934.80%
|
ROE
-224.90%
|
ROI
-191.60%
|
|
ROA
-126.40%
|
EPS Growth
-795.90%
|
Current Ratio
6.5
|
Debt/Equity
73.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $38.62 | - | - | 1.04B | Strong Buy |
| Cocrystal Pharma Inc (COCP) | $2.17 | - | - | 72.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 12.3M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.30 | - | - | 52.8M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.53 | - | - | 28.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
